secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2024-04-17T23:59:59+00:00
Accession:  0001493152-24-015044
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Choice FY2023 revenue falls 29% YoY to $38.6M; gross margin up to 31%, net loss narrows 42%
--------------------------------------------------------------------------------

- Net sales $38.6M vs $54.7M in 2022; decline driven by international stock normalization and exit of unprofitable accounts.
- Gross margin improved 300 bps to 31% due to strategic pricing and 3% reduction in input costs.
- Net loss improved 42% to $22.8M; EPS improved 45% to ($32.29) from ($58.93).
- Adjusted EBITDA improved 32% to ($8.0M); operating loss improved 45% to $21.2M.
- Q4 2023 operating loss improved 47% YoY to $12.7M; adjusted EBITDA improved 30% to ($3.4M).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000149315224015044/0001493152-24-015044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000149315224015044/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer